COMMUNIQUÉS West-GlobeNewswire

Agile Therapeutics Reports Second Quarter 2018 Financial Results
03/08/2018
Cash Expected to Enable Company to Fund Operations into Second Quarter 2019 PRINCETON, N.J., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported [...]
Imke Casey, DNP, CRNA, RHIT is Elected to the American Health Council’s Nurse Board
03/08/2018
NEW YORK, Aug. 03, 2018 (GLOBE NEWSWIRE) -- The American Health Council recently elected Imke Casey, DNP, CRNA, RHIT to its Board of Nurses. Currently a nurse anesthetist at the Indian Health Services Department, an [...]
Nephros Schedules Second Quarter Financial Results Conference Call
03/08/2018
Call scheduled for Wednesday, August 8 th at 4:30 PM EDT SOUTH ORANGE, NJ, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high [...]
Tetra Bio-Pharma Provides Extension to North Bud Farms
03/08/2018
ORLEANS, Ontario, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that the company has provided [...]
U.S. Centers for Medicare and Medicaid Services (CMS) Grants New Technology Add-On Payment for Portola Pharmaceuticals’ Andexxa
03/08/2018
– Add-on payment to support patient access by providing additional Medicare reimbursement in the hospital setting – SOUTH SAN FRANCISCO, Calif. , Aug. 03, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq [...]
Cue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of Directors
03/08/2018
CAMBRIDGE, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ:CUE) a next-generation immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
03/08/2018
--- Add-on Payment to Provide Additional Medicare Reimbursement up to 50% of the cost of ZEMDRI Prescribed to Medicare patients in Hospital Inpatient Setting --- SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE [...]
Spark Therapeutics Recognized for Second-straight Year as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal
03/08/2018
PHILADELPHIA, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has been [...]
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City
03/08/2018
RALEIGH, N.C., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases [...]
Oncolytics Biotech® Reports 2018 Second Quarter Results
03/08/2018
CALGARY, Alberta and SAN DIEGO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Aclaris Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments
03/08/2018
Management to Host Conference Call at 8:00 AM ET today WAYNE, Pa., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, [...]
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018
03/08/2018
RANCHO CUCAMONGA, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2018 ended June 30, 2018, after the [...]
HMS Holdings Corp. Reports Second Quarter 2018 Results
03/08/2018
Total Q2 Revenue of $146.8 Million / YTD Total Revenue Up 13% Excluding Q1 Reserve Release Record Quarterly Commercial Revenue of $80.5 Million in Q2 – Up 16% Compared to Q2’17 Full-Year 2018 Outlook Raised - Including [...]
Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy
03/08/2018
Company Appoints Greg Liposky, MBA as Senior Vice President of Commercial Manufacturing CLEVELAND, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced the addition of an experienced manufacturing [...]
William Demant: Investor news - William Demant and Philips partner in hearing healthcare
03/08/2018
Investor news 3 August 2018 William Demant and Philips partner in hearing healthcare Based on a shared vision of improving the lives of people through innovative healthcare, William Demant will bring Philips-branded [...]
Shire plc : Rule 2.9 Announcement
03/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 August 2018 [...]
Fagron realised organic turnover growth of 8.5%
03/08/2018
Regulated information | Consolidated results for the first semester of 2018 Nazareth (Belgium)/Rotterdam (the Netherlands), 3 August 2018 Fagron realised organic turnover growth of 8.5% Organic turnover growth in all [...]
HitGen Launching Initiative to Discover New Medicines to Combat Tuberculosis and Malaria
03/08/2018
Grant Funding provided by the Bill & Melinda Gates Foundation to Use HitGen’s DNA-Encoded Library Technology CHENGDU, China, Aug. 03, 2018 (GLOBE NEWSWIRE) -- HitGen Ltd., a privately held biotech company, announced [...]
Idera Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
02/08/2018
Abstract accepted for 2018 European Society of Medical Oncology Annual Meeting Cash runway into first quarter of 2020 EXTON, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a [...]

Pages